Access cutting-edge pediatric migraine treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access pediatric migraine specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pediatric migraine treatment provided free
The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine.
Sponsor: Pfizer
Check if you qualify for this pediatric migraine clinical trial in Washington Dc, DC
If you're searching for pediatric migraine treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pediatric migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.